Fibrinogen γ’ and variation in fibrinogen gamma genes in the etiology of portal vein thrombosis

• References

• 1 Uitte de Willige S, Standeven KF, Philippou H. et al. The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood 2009; 114: 3994-4001.
• 2 Grunbacher G, Weger W, Marx-Neuhold E. et al. The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis. Thromb Res 2007; 121: 33-36.
• 3 Nowak-Gottl U, Weiler H, Hernandez I. et al. Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies. Blood 2009; 114: 1947-1953.
• 4 Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ. et al. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 2005; 106: 4176-4183.
• 5 Uitte de Willige S, Pyle ME, Vos HL. et al. Fibrinogen gamma gene 3'-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population. Thromb Haemost 2009; 101: 1078-1084.
• 6 Plessier A, Darwish-Murad S, Hernandez-Guerra M. et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51: 210-218.
• 7 Cheung EY, Uitte de Willige S, Vos HL. et al. Fibrinogen gamma' in ischemic stroke: a case-control study. Stroke 2008; 39: 1033-1035.
• 8 Cheung EY, Vos HL, Kruip MJ. et al. Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood 2009; 114: 4603-4605.